January 11, 2024
The Ministry of Health, Labor and Welfare (MHLW) on January 10 issued a notification ordering label revisions for a batch of medicines, including I/O therapies Keytruda (pembrolizumab) and Tecentriq (atezolizumab) for the risk of myelitis. Myelitis will be added to...read more